Reimbursement by current German diagnosis-related groups system penalises complex congenital heart surgery

Nicodème Sinzobahamvya1, Thorsten Kopp2, Claudia Arenz1

  • 11 Department of Paediatric Thoracic and Cardiovascular Surgery, Deutsches Kinderherzzentrum Sankt Augustin, Sankt Augustin, Germany.

Insights

The German Diagnosis-Related Groups system underfunds complex congenital heart surgery by 17%. Higher complexity cases, assessed by the Aristotle complexity score, face increasing financial penalties, highlighting a need for system adjustment.

Area of Science:

  • Cardiology
  • Health Economics
  • Healthcare Management

Background:

  • The German Diagnosis-Related Groups (G-DRG) system is used for hospital reimbursement in Germany.
  • Congenital heart surgery is a complex and costly procedure.
  • Accurate reimbursement is crucial for maintaining the quality of care for these patients.

Purpose of the Study:

  • To evaluate whether the current German Diagnosis-Related Groups (G-DRG) system adequately covers the costs associated with congenital heart surgery.
  • To determine the extent of underfunding, if any, in the G-DRG system for these procedures.
  • To explore the correlation between surgical complexity and reimbursement adequacy.

Main Methods:

  • Analysis of 458 hospital stays for congenital heart surgery in 2011.
  • Cost estimation based on guidelines from the Institute for the Hospital Remuneration System.
  • Reimbursement calculation using 2012 cost-weight values and additional compensations.
  • Classification of cases using the Aristotle complexity score (Levels 1-6).
  • Statistical analysis, including Spearman's rank correlation coefficient and regression analysis.

Main Results:

  • Mean hospital costs were €30,597, while mean reimbursement was €25,514, resulting in an overall underfunding of 17%.
  • Fifty-nine percent of cases were classified as higher complexity (Levels 4-6) according to the Aristotle complexity score.
  • Hospital costs strongly correlated with complexity levels (Spearman's r = 0.89).
  • Underfunding increased linearly with complexity, from 6% for Level 1 to 23% for Level 6 procedures.

Conclusions:

  • The current German Diagnosis-Related Groups (G-DRG) system increasingly penalizes complex congenital heart surgery.
  • The Aristotle complexity score is a valuable tool that could help to address the identified underfunding issues.
  • Reimbursement adjustments based on complexity are necessary to ensure adequate financial coverage for congenital heart surgery.

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...